| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 766457 | 72526 | PANTOPRAZOL BLUEFISH 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL BLUEFISH 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72526/72526_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72526/72526_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20763 | BLUEFISH PHARMA S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2024-12-16 | 1 | 2025-09-03 | View Edit Delete | ||||||||||||
| 766458 | 72528 | PANTOPRAZOL BLUEFISH 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL BLUEFISH 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 56 comprimidos | 40 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72528/72528_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72528/72528_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20763 | BLUEFISH PHARMA S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2024-12-16 | 1 | 2025-09-29 | View Edit Delete | ||||||||||||
| 766459 | 90011 | PREGABALINA NORMON 100 MG COMPRIMIDOS EFG | PREGABALINA NORMON 100 MG COMPRIMIDOS EFG, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90011/90011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90011/90011_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766461 | 90010 | PREGABALINA NORMON 150 MG COMPRIMIDOS EFG | PREGABALINA NORMON 150 MG COMPRIMIDOS EFG, 56 comprimidos | 150 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90010/90010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90010/90010_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766462 | 90012 | PREGABALINA NORMON 200 MG COMPRIMIDOS EFG | PREGABALINA NORMON 200 MG COMPRIMIDOS EFG, 56 comprimidos | 200 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90012/90012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90012/90012_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766464 | 90013 | PREGABALINA NORMON 25 MG COMPRIMIDOS EFG | PREGABALINA NORMON 25 MG COMPRIMIDOS EFG, 56 comprimidos | 25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90013/90013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90013/90013_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766465 | 90014 | PREGABALINA NORMON 300 MG COMPRIMIDOS EFG | PREGABALINA NORMON 300 MG COMPRIMIDOS EFG, 56 comprimidos | 300 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90014/90014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90014/90014_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766466 | 90015 | PREGABALINA NORMON 50 MG COMPRIMIDOS EFG | PREGABALINA NORMON 50 MG COMPRIMIDOS EFG, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90015/90015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90015/90015_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 766467 | 90016 | PREGABALINA NORMON 75 MG COMPRIMIDOS EFG | PREGABALINA NORMON 75 MG COMPRIMIDOS EFG, 56 comprimidos | 75 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90016/90016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90016/90016_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 765616 | 89786 | PAZOPANIB GLENMARK 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB GLENMARK 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89786/89786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89786/89786_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2024-12-16 | 1 | 1 | 1 | 2024-12-16 | 2024-12-16 | 1 | 2025-11-14 | View Edit Delete | ||||||||||||
| 765623 | 89787 | PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | PAZOPANIB GLENMARK 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89787/89787_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89787/89787_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2024-12-16 | 1 | 1 | 1 | 2024-12-16 | 2024-12-16 | 1 | 2025-11-14 | View Edit Delete | ||||||||||||
| 766456 | 85763 | SYRACERIN 0,5 MG/G + 20 MG/G SOLUCION CUTANEA | SYRACERIN 0,5 MG/G + 20 MG/G SOLUCION CUTANEA, 1 frasco de 100 ml | 0,5 mg/g + 20 mg/g | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85763/85763_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85763/85763_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | MIBE PHARMA ESPAÑA S.L.U. | 2021-02-12 | 1 | 1 | 1 | 2021-02-13 | 2024-12-16 | 1 | 2025-08-31 | View Edit Delete | ||||||||||||
| 766472 | 90020 | VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG | VORICONAZOL SEACROSS 200 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG, 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90020/90020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90020/90020_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2024-12-16 | 1 | 1 | 1 | 2024-12-17 | 2024-12-16 | 1 | 2025-04-01 | View Edit Delete | ||||||||||||
| 766455 | 83900 | DICLOKERN FORTE 23,2 MG/G GEL | DICLOKERN FORTE 23,2 MG/G GEL, 1 tubo de 150 g | 20 mg/g | 44 | 150 | 21 | 1 tubo de 150 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83900/83900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83900/83900_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2019-03-05 | 1 | 1 | 1 | 2019-03-06 | 2024-12-13 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 766446 | 90003 | BICALUTAMIDA AUROVITAS 150 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | BICALUTAMIDA AUROVITAS 150 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 150 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90003/90003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90003/90003_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2024-12-11 | 1 | 1 | 1 | 2024-12-12 | 2024-12-11 | 1 | 2025-08-06 | View Edit Delete | ||||||||||||
| 766452 | 90007 | ACIDO VALPROICO SEACROSS 100 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION | ACIDO VALPROICO SEACROSS 100 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 5 viales de 4 ml | 100 mg/ml inyectable 4 ml | 45 | 5 | 34 | 5 viales de 4 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/90007/90007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90007/90007_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2024-12-11 | 1 | 1 | 1 | 2024-12-12 | 2024-12-11 | 1 | 2025-04-01 | View Edit Delete | ||||||||||||
| 766419 | 97051023IP3 | MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA | MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 2,1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97051023IP3/97051023IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97051023IP3/97051023IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | ECOFAR PRODUCTOS S.L. | 2024-12-10 | 1 | 1 | 1 | 2024-12-11 | 2024-12-10 | 0 | 2025-01-21 | View Edit Delete | ||||||||||||
| 766029 | 89896 | TIOTEPA VIVANTA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA VIVANTA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89896/89896_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89896/89896_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2024-12-09 | 1 | 1 | 1 | 2024-12-09 | 2024-12-09 | 0 | 2026-01-08 | View Edit Delete | ||||||||||||
| 766031 | 89897 | TIOTEPA VIVANTA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA VIVANTA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89897/89897_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89897/89897_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2024-12-09 | 1 | 1 | 1 | 2024-12-09 | 2024-12-09 | 0 | 2026-01-08 | View Edit Delete | ||||||||||||
| 766418 | 1241831010 | POMALIDOMIDA ACCORD 2 MG CAPSULAS DURAS EFG | POMALIDOMIDA ACCORD 2 MG CAPSULAS DURAS EFG, 21 cápsulas | 2 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241831010/1241831010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241831010/1241831010_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2024-09-03 | 1 | 1 | 1 | 2024-09-04 | 2024-12-05 | 1 | 2025-05-14 | View Edit Delete |
Page 47 of 1035, showing 20 records out of 20697 total, starting on record 921, ending on 940